Review Article

Pathobiology of Anaplastic Large Cell Lymphoma

Table 1

Main translocation involving ALK recorded in anaplastic large cell lymphoma.

Chromosomal translocationPartner geneFusion geneFrequency (5)ALK IHC detection

t(2;5)(p23;q35)NPM1NPM1/ALK75–80Cytoplasmic/nuclear
t(1;2)(q25;p23)TMP3TMP3/ALK12–18Cytoplasmic
inv(2)ATICATIC/ALK2Cytoplasmic
t(2;3)(p23;q21)TGFTGF/ALK2Cytoplasmic
t(2;17)(p23;q23)CLTLCLTL/ALK2Cytoplasmic
t(2;17)(p23;q25)ALO17ALO17/ALK<1Cytoplasmic
t(2;19)(p23;p13)TPM4TPM4/ALK<1Cytoplasmic
t(2;22)(p23;q11.2)MYH9MYH9/ALK<1Cytoplasmic
t(2;X)(p23;q11-12)MSNMSN/ALK<1Membranous

NPM1: nucleophosmin; ALK: anaplastic lymphoma kinase; TPM3: tropomyosin 3; ATIC: 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase; TGF: TRK-fused gene; CLTL: Clathrin heavy chainlike 1; ALO17: ALK lymphoma oligomerization partner on chromosome 17; TPM4: tropomyosin 4; MYH9: Nonmuscle myosin heavy chain; MSN: moesin; IHC: immunohistochemistry.